West Pharmaceutical Services, Inc. (WST)

West Pharmaceutical Services (WST) Financial Statements


West Pharmaceutical Services Financial Overview

West Pharmaceutical Services's market cap is currently ―. The company's EPS TTM is $7.729; its P/E ratio is 43.45; and it has a dividend yield of 0.22%. West Pharmaceutical Services is scheduled to report earnings on April 27, 2023, and the estimated EPS forecast is $1.65. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 708.70M$ 686.90M$ 771.30M$ 720.00M$ 730.80M
Gross Profit$ 262.10M$ 268.00M$ 321.50M$ 284.60M$ 300.60M
EBIT$ 130.40M$ 138.40M$ 229.40M$ 190.00M$ 184.50M
EBITDA$ 161.50M$ 168.20M$ 259.50M$ 219.60M$ 218.90M
Net Income Common Stockholders$ 103.00M$ 120.60M$ 188.50M$ 173.80M$ 147.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 894.30M$ 729.00M$ 718.50M$ 667.70M$ 762.60M
Total Assets$ 3.62B$ 3.32B$ 3.36B$ 3.29B$ 3.31B
Total Debt$ 317.90M$ 299.90M$ 332.50M$ 331.20M$ 325.30M
Net Debt$ -576.40M$ -429.10M$ -386.00M$ -336.50M$ -437.30M
Total Liabilities$ 931.90M$ 846.00M$ 937.30M$ 968.50M$ 978.40M
Stockholders Equity$ 2.68B$ 2.47B$ 2.42B$ 2.33B$ 2.34B
Cash Flow-
Free Cash Flow$ 135.90M$ 111.10M$ 107.00M$ 85.40M$ 84.30M
Operating Cash Flow$ 230.80M$ 168.90M$ 173.10M$ 151.20M$ 160.80M
Investing Cash Flow$ -94.80M$ -59.10M$ -66.00M$ -68.30M$ -77.40M
Financing Cash Flow$ -9.50M$ -75.20M$ -36.20M$ -172.70M$ -6.20M
Currency in USD

West Pharmaceutical Services Earnings and Revenue History

West Pharmaceutical Services Debt to Assets

West Pharmaceutical Services Cash Flow

West Pharmaceutical Services Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis